SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-19-040450
Filing Date
2019-02-14
Accepted
2019-02-14 15:08:32
Documents
1
Group Members
ALAN FRAZIERBRIAN MORFITTFHM VII, L.L.C.FHM VII, L.P.FRAZIER HEALTHCARE VII-A,L.P.JAMES TOPPERNADER NAININATHAN EVERYPATRICK HERON

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d659345dsc13ga.htm SC 13G/A 182916
  Complete submission text file 0001193125-19-040450.txt   184802
Mailing Address 601 UNION STREET SUITE 3200 SEATTLE WA 98101
Business Address 601 UNION STREET SUITE 3200 SEATTLE WA 98101 206-254-7200
Frazier Healthcare VII, L.P. (Filed by) CIK: 0001553071 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 1000 CONTINENTAL DRIVE SUITE 600 KING OF PRUSSIA PA 19406
Business Address 56 FITZWILLIAM SQUARE DUBLIN L2 2 (610) 816-6640
Nabriva Therapeutics plc (Subject) CIK: 0001641640 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-89113 | Film No.: 19605132
SIC: 2834 Pharmaceutical Preparations